EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ultrathin-strut drug-eluting stents are associated with lower revascularization rates than drug-coated balloons in non-focal in-stent restenosis

Berhan Keskin, Aykun Hakgor, Atakan Dursun, Aysel Akhundova, Umeyir Savur, Ebubekir Yigitbay, Ozlem Onder, Beytullah Cakal, Zubeyde Bayram, Bulent Demir, Haci Murat Gunes, Ibrahim Oguz Karaca und 2 weitere

Frontiers in Cardiovascular Medicine · 03.08.2026 · 13

DOI: 10.3389/fcvm.2026.1865693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.08.2026. Verfasst von Berhan Keskin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Istanbul Medipol University, Medipol Mega University Hospital, Istanbul, Türkiye. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In-stent restenosis (ISR) remains a significant clinical challenge despite advances in drug-eluting stent (DES) technology. Although current guidelines recommend drug-coated balloon (DCB) angioplasty or repeat DES implantation for DES-ISR, real-world data comparing DCB with newer-generation ultrathin-strut sirolimus-eluting stents (SES) are limited.

Methods

This retrospective, single-center study included consecutive patients with stable angina who underwent treatment for DES-ISR using either a paclitaxel-coated DCB or an ultrathin-strut SES between January 2015 and May 2025. The primary outcome was target-lesion revascularization (TLR). Secondary endpoints included major adverse cardiac events (MACE), defined as a composite of all-cause mortality, myocardial infarction, stroke, and TLR. Time-to-event analyses were performed using Kaplan–Meier methods and Cox proportional hazards regression.

Results

A total of 205 patients were included (DCB, n = 106; SES, n = 99), with a median follow-up of 863 days. In the overall cohort, TLR rates were comparable between groups. However, in the non-focal ISR subgroup, TLR was significantly higher in the DCB group compared with SES (34.1% vs. 12.7%, p = 0.024). Similarly, MACE rates were higher with DCB in non-focal ISR (39.0% vs. 18.2%, p = 0.041). No differences were observed in focal ISR. Multivariable analysis in the non-focal subgroup identified DCB treatment (HR 3.89, p = 0.006) as independent predictor of TLR. Kaplan–Meier analyses for TLR and MACE consistently demonstrated significantly worse outcomes with DCB in the non-focal ISR subgroup, whereas no significant differences were observed in focal ISR.

Conclusions

Ultrathin-strut SES was associated with lower TLR and MACE rates compared with DCB in non-focal DES-ISR, whereas outcomes were comparable in focal ISR. These findings highlight the importance of lesion characteristics and support a tailored approach to ISR management.

Schlagwörter

Stichwörter der Autor:innen

drug-coated balloondrug-eluting stentin-stent restenosistarget-lesion revascularizationultrathin-strut

Autor:innen und Institutionen

  • Department of Cardiology, Istanbul Medipol University, Medipol Mega University Hospital, Istanbul, Türkiye.

Zitieren

APA

Keskin, B., Hakgor, A., Dursun, A., Akhundova, A., Savur, U., Yigitbay, E., Onder, O., Cakal, B., Bayram, Z., Demir, B., Gunes, H. M., Karaca, I. O., Guler, E., & Boztosun, B. (2026). Ultrathin-strut drug-eluting stents are associated with lower revascularization rates than drug-coated balloons in non-focal in-stent restenosis. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1865693

Vancouver

Keskin B, Hakgor A, Dursun A, Akhundova A, Savur U, Yigitbay E, et al. Ultrathin-strut drug-eluting stents are associated with lower revascularization rates than drug-coated balloons in non-focal in-stent restenosis. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1865693

BibTeX
@article{Keskin2026,
  author = {Keskin, Berhan and Hakgor, Aykun and Dursun, Atakan and Akhundova, Aysel and Savur, Umeyir and Yigitbay, Ebubekir and Onder, Ozlem and Cakal, Beytullah and Bayram, Zubeyde and Demir, Bulent and Gunes, Haci Murat and Karaca, Ibrahim Oguz and Guler, Ekrem and Boztosun, Bilal},
  title = {Ultrathin-strut drug-eluting stents are associated with lower revascularization rates than drug-coated balloons in non-focal in-stent restenosis},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1865693}
}
Kostenlos starten →